Silver Book Fact

A one percent reduction in lung, colorectal, breast, leukemia, pancreatic, and brain cancer mortality would reduce productivity costs by $814 million per year.

Bradley, C, K Yabroff, B Dahman, E Feuer, A Mariotto, et al. Productivity Costs of Cancer Mortality in the United States: 2000-2020. J Natl Cancer Inst. 2008; 100(24): 1763-70. http://www.ncbi.nlm.nih.gov/pubmed/19066273

Reference

Title
Productivity Costs of Cancer Mortality in the United States: 2000-2020
Publication
J Natl Cancer Inst
Publication Date
2008
Authors
Bradley, C, K Yabroff, B Dahman, E Feuer, A Mariotto, et al.
Volume & Issue
Volume 100, Issue 24
Pages
1763-70
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • A 10 percent reduction in cancer-related deaths in the U.S. would be worth an estimated $4.4 trillion to current and future generations.  
  • After one year, 73 percent of non-small-cell lung cancer patients with the EGFR genetic mutation who were treated with a tyrosine kinase inhibitor had survived, compared to 15 percent who…  
  • Close to one third of all drugs currently in the biopharmaceutical pipeline are for cancer, with around 5,500 potential first-in-class cancer medicines in development.  
  • Investments in cancer research and development between 1998 and 2000 has generated 23 million additional healthy years of life and $1.9 trillion of additional social value.  
  • Colorectal Cancer Screening: Trends, 2003-2006